These findings indicate that the administration of Fasl in U-CH1 cell line is able to counteract the role of the anti-apoptotic form of Fas and induces the apoptotic pathway via Pro Caspase 8, suggesting that this pathway can be modulated in this tumor. This evidence concerns the gene CASP8 and neoplasm.